Latest stories on HROW
Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026
GlobeNewswire50 · neutralearnings
Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026
Business Insider50 · neutralearnings
Harrow: Q3 Needs To Prove The Turnaround Is Real
Seeking Alpha63 · neutralanalyst
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio
TipRanks63 · neutralm&a
HARROW, INC. (HROW) files 8-K
SEC 8-K50 · neutralgeneral
Harrow Closes Acquisition of TYRVAYA®
Business Insider62 · neutralm&a
Harrow Closes Acquisition of TYRVAYA®
GlobeNewswire62 · neutralm&a
Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
Business Insider63 · neutralproduct/pr
Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
GlobeNewswire67 · bullishproduct/pr
Leerink bullish on Harrow, initiates with an Outperform
The Fly61 · neutralanalyst
Harrow initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Harrow Health Streamlines Senior Finance and Accounting Leadership
TipRanks50 · neutralgeneral
HARROW, INC. (HROW) files 8-K
SEC 8-K50 · neutralgeneral
Mike Ashley to Fight for Majority Control of Hugo Boss
Yahoo Top48 · neutralm&a
Harrow to Participate in Three Investor Conferences in September
GlobeNewswire56 · neutralgeneral
Harrow to Participate in Three Investor Conferences in September
Business Insider56 · neutralgeneral
Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target
Yahoo Finance48 · neutralgeneral
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
StockTitan63 · neutralproduct/pr
Harrow (HROW) Q2 2026 Earnings Call Transcript
Yahoo Top73 · bullishearnings
Harrow (HROW) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
Yahoo Top63 · neutralm&a
Harrow: The Q2 Turnaround Is Enough For A Cautious Buy
Seeking Alpha56 · neutralanalyst
Harrow reiterates $350M-$365M 2026 revenue outlook as TYRVAYA is expected to add more than $30M in 2027 revenue
Seeking Alpha56 · neutralproduct/pr
Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Harrow Q2 Earnings Call Highlights
Yahoo Finance63 · neutralearnings